bioAffinity Technologies (BIAFW) Cash from Investing Activities (2023 - 2026)
bioAffinity Technologies (BIAFW) posted quarterly Cash from Investing Activities of -$5663.0 for Q1 2026, up 88.85% YoY from -$2998.7 in Q1 2025, and down 566200.0% sequentially from -$1.0 in Q4 2025.
bioAffinity Technologies (BIAFW) Cash from Investing Activities (2023 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed Cash from Investing Activities across 4 years of filings, most recently posting -$5663.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 88.85% year-over-year to -$5663.0; the TTM figure through Mar 2026 stood at -$15445.0 (up 82.54% YoY), while the FY2025 annual figure was -$60568.0, up 23.41% from the prior year.
- Cash from Investing Activities eased to -$5663.0 in Q1 2026, from -$1.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for BIAFW reached as high as $13442.0 in Q4 2023 and fell as low as -$2.2 million in Q3 2023.
- The 4-year median for Cash from Investing Activities is -$9410.0 (2024), against an average of -$181131.8.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities tumbled 632.58% — and 2025, when it surged 138.75%.
- A 4-year view of Cash from Investing Activities shows it stood at $13442.0 in 2023, then plunged by 100.01% to -$1.0 in 2024, then changed by 0.0% to -$1.0 in 2025, then sank by 566200.0% to -$5663.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$5663.0, -$1.0, and $3646.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | bioAffinity Technologies | - | - | - | -5,663.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,663.00 |
| Mar 31, 2026 | -5,663.00 |
| Dec 31, 2025 | -1.00 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | 3,646.00 |
| Sep 30, 2025 | 3,646.00 |
| Jun 30, 2025 | -13,427.00 |
| Jun 30, 2025 | -13,427.00 |
| Mar 31, 2025 | -50,786.00 |
| Mar 31, 2025 | -50,786.00 |
| Dec 31, 2024 | -1.00 |
| Dec 31, 2024 | -1.00 |
| Sep 30, 2024 | -9,410.00 |
| Sep 30, 2024 | -9,410.00 |
| Jun 30, 2024 | -28,285.00 |
| Jun 30, 2024 | -28,285.00 |
| Mar 31, 2024 | -41,387.00 |
| Mar 31, 2024 | -41,387.00 |
| Dec 31, 2023 | 13,442.00 |
| Dec 31, 2023 | 13,442.00 |